YT
Publicaties op Oncologisch.com
Final analysis of nivolumab plus cabozantinib for gevorderd renal cell carcinoma from the gerandomiseerde phase III C...
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA resul...
Avelumab + axitinib versus sunitinib as eerstelijns treatment for patiënten met gevorderd renal cell carcinoma: final...
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year...